Farkas, Sarah
NYU Langone Health · New York University
2 papers on CoChat
Most cited papers
- Verified
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., Farkas, S., Fishman, M., Gauthier, P., Hodgkins, C. C., et al. (2018) · The Lancet
Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes
Cited by 700
- Verified
Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff
McNeely, J., Kumar, P. C., Rieckmann, T., Sedlander, E., Farkas, S., Chollak, C., Kannry, J. L., Vega, A., Waite, E. A., Peccoralo, L. A., et al. (2018) · Addiction Science & Clinical Practice
Substance Abuse Treatment and OutcomesHealth Policy Implementation Science
Cited by 303
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free